On November 4, Aehr Test fell 8.29% in Regular Trading, trading at $59.085, with turnover of $101 million.
The most relevant catalyst cited in recent market coverage is that the stock pulled back after a sharp prior-session rally that followed stronger-than-expected fiscal first-quarter results and a higher full-year revenue outlook.
Previously disclosed figures showed adjusted EPS of $0.28 versus a $0.11 market expectation, while revenue reached $33.007 million versus an expected $27.072 million. The company also said backlog stood at $100.9 million as of September 25 and highlighted additional AI chip testing demand, including new orders tied to burn-in and test systems.
(The above content is based on publicly available market information, generated by a program or algorithm, and is intended solely as a stock movement alert. It does not constitute investment advice or a basis for trading decisions.)
Comments